Globe Life
$165.68Change from previous close: −0.09%Absolute change: −$0.15
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $12.8B
- Enterprise value
- $15.72B
- P/E (trailing 12 months)
- 11.1
- Forward P/E
- 10.1
- PEG
- 1.30
- Price/book
- 2.08
- Price/sales
- 2.07
- EV/EBITDA
- 9.35
- EV/revenue
- 2.54
Profitability and growth
- Gross margin
- 33.9%
- Operating margin
- 24.6%
- Net margin
- 19.6%
- ROE
- 20.9%
- ROA
- 3.4%
- Revenue growth (year over year)
- 8.0%
- Earnings growth (year over year)
- 19.7%
Financial health
- Total cash
- $455.38M
- Total debt
- $3.43B
- Debt/equity
- 0.56
- Current ratio
- 0.80
- Quick ratio
- 0.64
Dividends
- Annual dividend per share
- $1.32
- Dividend yield
- 0.8%
- Payout ratio
- 8.0%
- Ex-dividend date
- October 5, 2026
Analysts and estimates
- Average price target
- $193.91
- Median price target
- $192.00
- High price target
- $225.00
- Low price target
- $166.00
- Analysts with a price target
- 11
- Forward EPS
- $16.52
- EPS estimate, current year
- $15.71
Shares and trading
- Beta
- 0.46
- Average volume
- 543.15K
- Shares outstanding
- 76.85M
- Float
- 76.13M
- Institutional ownership
- 87.3%
- Insider ownership
- 0.7%
- Short interest (% of float)
- 0.1%
- Short ratio (days)
- 0.08